Navigation Links
Upcoming Beckman Coulter Investor Events Second Half of 2008
Date:6/13/2008

ORANGE COUNTY, Calif., June 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

-- Q2 2008 Earnings Release scheduled for Friday, July 25, 2008.

-- July 28 - 31, 2008, Washington, DC - The American Association for

Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition.

-- AACC will host its annual IVD Industry Analyst Briefing on Monday

afternoon, July 28, 2008, from 1:30 p.m. to 5:30 p.m. at the

Renaissance Marriott Hotel, Congressional Hall A. To RSVP, email:

ftellez@aacc.org.

-- Beckman Coulter will host an investor event Tuesday, July 29, from

7:30 a.m. to 9:00 a.m. To receive full details, RSVP directly to

Investor Relations at (714) 773-7620 or cgskoglund@beckman.com.

-- Industry Exhibits open on Tuesday, July 29 to Thursday, July 31,

2008 at the Walter E. Washington Convention Center, Washington, DC.

-- For general meeting information, go to http://www.aacc.org.

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DURECT Corporation to Participate in Upcoming Healthcare Conferences
2. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
3. ViroPharma to Present at Two Upcoming Healthcare Conferences
4. Cynosure Announces Schedule of Upcoming Investor Conferences
5. Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
6. Martek to Present at Upcoming UBS Conference
7. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
8. AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting
9. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
10. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
(Date:5/17/2013)... RURO Inc. is pleased to ... versatile refinement to the smart management solution. , ... advanced methodical management for transgenic animal colonies, genotyping ... network-based platform provides user access with a plethora ... to emphasize streamlined tasks, such as animal relocation ...
(Date:5/17/2013)... May 17, 2013 Tooth decay is an ... active signs of the disease. The World Health Organization says ... 100% of adults have cavities. What are the long-term effects ... showing a strong connection between the oral bacterial imbalance and ... disease so rampant, yet it is also 100% preventable? Answer: ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Oct. 3 The Connecticut Technology,Council and UHY LLP ... in Connecticut. The list of winning companies, called the ... of revenue growth over the last four,years. Companies considered ... some of the public companies winning this year exceeding,$1Billion ...
... Oct. 3 ( http://www.amdl.com ),AMDL, Inc. (Amex: ... operations in China and the US, today announced that ... Conference in New,York City on Tuesday, October 7, 2008 ... the Grand Hyatt New York Hotel in the Morosco ...
... October 3 Simbionix, the world,s,leading developer ... theoretical promise to operating room reality., ... simulation system, is the world,s first medical ... based on their patient,s,unique pathology and anatomy., ...
Cached Biology Technology:Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3Simbionix Launches Innovative Patient-Specific Simulation 2
(Date:5/16/2013)... outside the bone marrow in the liver, the ... now show that a specific type of immune cell ... Balanced hematopoiesis is essential for the function of the ... in the liver and the spleen. Later the process ... normally serves as the sole source of blood cells ...
(Date:5/16/2013)... us don,t ponder our pulses outside of the gym. But ... monitor heart health. , Zhenan Bao, a professor of chemical ... a dollar bill and no wider than a postage stamp. ... the wrist, is sensitive enough to help doctors detect stiff ... be used to continuously track heart health and provide doctors ...
(Date:5/15/2013)... molecules that have powerful behavioral effects on diverse ... structuring ecosystems, according to a theory proposed in ... authors of the theory, Ryan P. Ferrer of ... the University of California at Los Angeles, liken ... that may be uncommon but exert a controlling ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Natural 'keystone molecules' punch over their weight in ecosystems 2
... to be stored on ... next evolution of e-passports, DALLAS, ... emerging standards and technology, are,leading governments across the world to ... to their citizens.,Entrust, Inc. (Nasdaq: ENTU ), a leader ...
... present can tell you a lot about the past, ... new study appearing this month in Genome Research reveals ... regions within proteins provide an extraordinary window on ... at the University of Illinois describe contemporary protein architectures ...
... COLD SPRING HARBOR, N.Y. (Mon., Oct. 1, 2007) ... to provide knowledge about biological mechanisms that underlie our ... us. To facilitate such research, two neuroscience methods are ... Harbor Protocols . Both are freely accessible online ( ...
Cached Biology News:Entrust Continues Leadership by Adding Support for Next-generation E-Passports 2Entrust Continues Leadership by Adding Support for Next-generation E-Passports 3Census of protein architectures offers new view of history of life 2Census of protein architectures offers new view of history of life 3Census of protein architectures offers new view of history of life 4From brains to behavior: Cold Spring Harbor Protocols features methods for neuroscience research 2
Human Cell Line Slides...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
6X Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Biology Products: